Lysergic acid diethylamide (LSD) has a long and colorful history in psychiatric research. Over the last 75 years, waves of excitement have been quickly tempered by waves of fear. For decades, controversies, counterculture, and conservative crackdowns have dampened its potential as a powerful treatment for mental health. But, as a new wave of contemporary research …
In early 2022, Canada became one of the first developed countries to allow patients limited access to psychedelic therapies. Only available for emergency purposes and specifically for patients experiencing treatment-resistant conditions, this change may represent a new era of regulated psychedelic-assisted treatment options. Canada is taking a tentative approach, but one that is guided by …
Diving into Canada’s Psychedelic Therapy Program Read More »
Psychedelic drugs are experiencing a rapid evolution. In only a few short years, formerly demonized substances like LSD and magic mushrooms have become the darlings of medical researchers. Psilocybin, the hallucinogenic compound derived from magic mushrooms, is notably garnering attention for its powers over conditions like anxiety, depression, and cluster headaches. Several American municipalities …
Is Psilocybin a Magic Potion for Mental Health and Other Conditions? Read More »
Riding the wave of medical cannabis legislation and research, new (or perhaps renewed) attention is being directed at the potential of psychedelic medicines. Psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and ketamine are just a few of the psychedelic substances already well into clinical trials. With a global market predicted to reach anywhere …
We never spam your inbox. You will always get the most accurate news and updates, signup now!
